Citations 1
FIRST‐MIND: A PHASE IB, OPEN‐LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL
Kopečková, Kateřina , Burgués, Juan Miguel Bergua, Pichler, P. , Klöpfer, Pia, Brackertz, Bettina, Lohrmann, E., Lahiry, Anirban , Shah, Neha , Brugger, Wolfram, Burke, John M. , Nowakowski, Grzegorz S. , Belada, David , André, Marc , Persona, Ernesto Pérez
Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available
